Eledon Pharmaceuticals (ELDN)
NASDAQ:ELDN
Want to see ELDN full AI Analyst Report?
Eledon Pharmaceuticals (ELDN) Ownership Overview
0.03% Insiders
6.87% Mutual Funds
0.32% Other Institutional Investors
8.56% ETFs
84.21% Public Companies and
Individual Investors
The ownership structure of Eledon Pharmaceuticals (ELDN) stock is a mix of institutional, retail, and individual investors. Approximately 15.76% of the company’s stock is owned by Institutional Investors, 0.03% is owned by Insiders, and 84.21% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2023 | xxxxxxxxxxxxx | $106093 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,643,596 | Institution | 4.80% | 12,625,060 | |
| 3,566,338 | Institution | 4.70% | 12,357,361 | |
| 3,167,737 | Institution | 4.18% | 10,976,209 | |
| 2,510,403 | Institution | 3.31% | 8,698,546 | |
| 800,822 | Institution | 1.06% | 2,774,848 | |
| 633,927 | Institution | 0.84% | 2,196,557 | |
| 613,106 | Institution | 0.81% | 2,124,412 | |
| 317,979 | Institution | 0.42% | 1,101,797 | |
| 173,131 | Institution | 0.23% | 599,899 | |
| 98,585 | Institution | 0.13% | 341,597 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,167,737 | Institution | 4.18% | 10,976,209 | |
| 633,927 | Institution | 0.84% | 2,196,557 | |
| 613,106 | Institution | 0.81% | 2,124,412 | |
| 317,979 | Institution | 0.42% | 1,101,797 | |
| 173,131 | Institution | 0.23% | 599,899 | |
| 76,292 | Institution | 0.10% | 264,352 | |
| 43,564 | Institution | 0.06% | 150,949 | |
| 37,731 | Institution | 0.05% | 130,738 | |
| 35,863 | Institution | 0.05% | 124,265 | |
| 27,288 | Institution | 0.04% | 94,553 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,356,062 | Institution | 3.11% | 7,256,671 | |
| 1,690,824 | Institution | 2.23% | 5,858,705 | |
| 857,645 | Institution | 1.13% | 2,641,547 | |
| 590,787 | Institution | 0.78% | 2,047,077 | |
| 369,195 | Institution | 0.49% | 1,137,121 | |
| 189,469 | Institution | 0.25% | 656,510 | |
| 81,166 | Institution | 0.11% | 291,386 | |
| 53,358 | Institution | 0.07% | 164,343 | |
| 39,323 | Institution | 0.05% | 136,254 | |
| 32,279 | Institution | 0.04% | 115,882 |
FAQ
Who Owns Eledon Pharmaceuticals (ELDN)?
According to the latest TipRanks data, approximately 0.32% of the company's stock is held by institutional investors, 0.03% is held by insiders, and 84.21% is held by retail investors.
What percentage of Eledon Pharmaceuticals (ELDN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.32% of Eledon Pharmaceuticals (ELDN) stock is held by institutional investors.
What percentage of Eledon Pharmaceuticals (ELDN) stock is held by retail investors?
According to the latest TipRanks data, approximately 84.21% of Eledon Pharmaceuticals (ELDN) stock is held by retail investors.
Who owns the most shares of Eledon Pharmaceuticals (ELDN)?
Vanguard owns the most shares of Eledon Pharmaceuticals (ELDN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.